跳至主要内容
临床试验/KCT0002651
KCT0002651招募中未知

A randomized, double-blind, placebo-controlled trial of ramosetron in patients with fibromyalgia.

Chonnam National University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • Patients between 18 and 80 years of age who meet the following criteria:
  • Disease: The definition of fibromyalgia is based on the criteria published by the American Society of Rheumatology (ACR) in 2010, and the patients who meet the following criteria are eligible.
  • 1) The patients who meet the 2010 ACR criteria for fibromyalgia
  • 2) No response after 4 weeks of standard medication
  • 3) Pain VAS 40 and FIQ score of 45 or more
  • 4) The patients who are fully informed about the study and signed the informed consent.

排除标准

  • 1) Patients complaining of pain due to other rheumatic diseases.
  • 2) The patients who had a certain diseases such as uncontrolled tumors
  • 3) If patients have uncontrolled illness or psychiatric illness
  • 4) If patients have a history of drug addiction
  • 5) Patients who are pregnant or expect to become pregnant
  • 6) If there is a previous history of study drug use before 30 days
  • 7) Patients with severe complications due to drug allergy
  • are excluded from this study.

研究者

相似试验

A randomized, double-blind, placebo-controlled trial... | 临床试验